Epijoint®, the new product easing mild osteoarthritis symptoms
Epijoint® relieves mild joint pain, eases mild osteoarthritis symptoms and supports joint mobility.
Learn moreIn a recent human clinical trial examining the effects of Epiitalis® on reducing symptoms of mild osteoarthritis, results demonstrated a number of positive health outcomes for patients taking a daily dose of 160mg of Epiitalis®
To learn more about the results of Epiitalis®, see our human clinical study below.
Mitchell P. G., et. al. Inflammopharmacology. 2022 Aug; 30(4):1323-1334. Interpath sponsored study. Research conducted by Vedic Lifesciences.
Read moreA world-exclusive ingredient
Sustainably sourced and derived from a plant seed oil high in unique fatty acids, Epiitalis® is the active ingredient powering Epijoint®. Epiitalis® is patented for its anti-inflammatory properties and ability to help maintain healthy joint cartilage growth.
Learn moreFrequently asked questions
Epiitalis®, the proprietary ingredient in Epijoint®, is harnessed from a plant seed oil, comprised of fatty acids. Epiitalis® is globally patented for its anti-inflammatory properties and cartilage health benefits.
The recommended daily dosage is 2 capsules per day. Up to 4 capsules can be taken if necessary.
Talk to your prescribing medical practitioner before taking other medicines.
While individual results vary, most people report an improvement in 7 to 30 days after consistent daily use.
- Choosing a selection results in a full page refresh.
- Opens in a new window.